scholarly article | Q13442814 |
P2093 | author name string | Christopher D Link | |
Susan Wang | |||
Shin Murakami | |||
Hana Murakami | |||
Kevin Machino | |||
P2860 | cites work | Amyloid beta: multiple mechanisms of toxicity and only some protective effects? | Q27008826 |
Keeping track of worm trackers | Q27012579 | ||
Alzheimer's disease: genes, proteins, and therapy | Q28131806 | ||
Maintenance of C. elegans | Q29617844 | ||
Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss | Q30420041 | ||
High-throughput behavioral analysis in C. elegans | Q30501986 | ||
Thermotaxis is a robust mechanism for thermoregulation in Caenorhabditis elegans nematodes | Q30566713 | ||
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans | Q33902367 | ||
Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view | Q34268430 | ||
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models | Q34418781 | ||
Drosophila melanogaster as a model organism for Alzheimer's disease | Q34464181 | ||
β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons | Q35872520 | ||
Neurologic and motor dysfunctions in APP transgenic mice | Q36347389 | ||
Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease | Q36460071 | ||
Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease | Q36949391 | ||
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census | Q37035610 | ||
Biomarker modeling of Alzheimer's disease | Q37592824 | ||
Pathways linking Abeta and tau pathologies. | Q37775659 | ||
The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis | Q37953181 | ||
Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease | Q38078146 | ||
Frailty among Alzheimer's disease patients | Q38097898 | ||
Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity | Q38139529 | ||
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target? | Q38912261 | ||
Thermotaxis in Caenorhabditis elegans analyzed by measuring responses to defined Thermal stimuli. | Q43030766 | ||
Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta | Q43181445 | ||
Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease | Q46318965 | ||
Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis | Q46569493 | ||
Aging-dependent and -independent modulation of associative learning behavior by insulin/insulin-like growth factor-1 signal in Caenorhabditis elegans. | Q48942620 | ||
Association between frailty and dementia: a population-based study. | Q50694550 | ||
Manipulation of serotonin signal suppresses early phase of behavioral aging in Caenorhabditis elegans. | Q51992813 | ||
P921 | main subject | Caenorhabditis elegans | Q91703 |
overexpression | Q61643320 | ||
P304 | page(s) | 202 | |
P577 | publication date | 2014-07-04 | |
P1433 | published in | Frontiers in Genetics | Q2499875 |
P1476 | title | A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons | |
P478 | volume | 5 |
Q34010229 | Alzheimer's patient feedback to complement research using model systems for cognitive aging and dementia |
Q58775193 | D-Track-A semi-automatic 3D video-tracking technique to analyse movements and routines of aquatic animals with application to captive dolphins |
Q59808737 | Frailty and as a Benchtop Animal Model for Screening Drugs Including Natural Herbs |
Q41497184 | In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model. |
Q51533022 | Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease. |
Search more.